Chibaudel, B., Bonnetain, F., Tournigand, C., de Larauze, M. H., de Gramont, A., Laurent-Puig, P., . . . de Gramont, A. (2015). STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer. BMC Cancer.
Styl cytowania ChicagoChibaudel, Benoist, et al. "STRATEGIC-1: A Multiple-lines, Randomized, Open-label GERCOR Phase III Study in Patients With Unresectable Wild-type RAS Metastatic Colorectal Cancer." BMC Cancer 2015.
Styl cytowania MLAChibaudel, Benoist, et al. "STRATEGIC-1: A Multiple-lines, Randomized, Open-label GERCOR Phase III Study in Patients With Unresectable Wild-type RAS Metastatic Colorectal Cancer." BMC Cancer 2015.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..